Showing results (151-160 of 641) with videos related to

Sort By:
Pageof 65
JMIR Cancer|October 12, 2021
Measuring the Time to Deterioration for Health-Related Quality of Life in Patients With Metastatic Breast Cancer Using a Web-Based Monitoring Application: Longitudinal Cohort StudyKatharina Brusniak, Manuel Feisst, Linda Sebesteny, et al.
JMIR Cancer|July 29, 2022
Providing Care Beyond Therapy Sessions With a Natural Language Processing-Based Recommender System That Identifies Cancer Patients Who Experience Psychosocial Challenges and Provides Self-care Support: Pilot StudyYvonne W Leung, Bomi Park, Rachel Heo, et al.
JMIR Cancer|September 18, 2015
Lifestyle Modification Experiences of African American Breast Cancer Survivors: A Needs AssessmentSelina A Smith, Mechelle D Claridy, Mary Smith Whitehead, et al.
JMIR Cancer|July 22, 2022
An Investigation of Virtual Reality Nature Experiences in Patients With Metastatic Breast Cancer: Secondary Analysis of a Randomized Controlled TrialStanley Chin, Alana Cavadino, Amelia Akroyd, et al.
JMIR Cancer|August 2, 2019
Digital Interventions to Support Adolescents and Young Adults With Cancer: Systematic ReviewLisa McCann, Kathryn Anne McMillan, Gemma Pugh
JMIR Cancer|April 7, 2025
Digital Health Intervention to Reduce Malnutrition Among Individuals With Gastrointestinal Cancer Receiving Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy: Feasibility, Acceptability, and Usability TrialYu Chen Lin, Ryan Hagen, Benjamin D Powers, et al.
JMIR Cancer|May 2, 2025
Examining Demographic, Geographic, and Temporal Patterns of Melanoma Incidence in Texas From 2000 to 2018: Retrospective StudyKehe Zhang, Madison M Taylor, Jocelyn Hunyadi, et al.
JMIR Cancer|April 16, 2025
Assessing the Quality and Reliability of ChatGPT's Responses to Radiotherapy-Related Patient Queries: Comparative Study With GPT-3.5 and GPT-4Ana Grilo, Catarina Marques, Maria Corte-Real, et al.
JMIR Cancer|May 6, 2025
Comparison of Electronic Surveillance With Routine Monitoring for Patients With Lymphoma at High Risk of Relapse: Prospective Randomized Controlled Phase 3 Trial (Sentinel Lymphoma)Katell Le Dû, Adrien Chauchet, Sophie Sadot-Lebouvier, et al.
JMIR Cancer|May 5, 2025
Leveraging Artificial Intelligence for Digital Symptom Management in Oncology: The Development of CRCWebSizuo Liu, Yufen Lin, Runze Yan, et al.
Pageof 65